Optimization of combined proton-photon treatments.
暂无分享,去创建一个
Matthias Guckenberger | Jan Unkelbach | Mark Bangert | J. Unkelbach | M. Guckenberger | N. Andratschke | M. Bangert | Nicolaus Andratschke | Karen De Amorim Bernstein | K. L. de Amorim Bernstein
[1] Harald Paganetti,et al. Predicting Patient-specific Dosimetric Benefits of Proton Therapy for Skull-base Tumors Using a Geometric Knowledge-based Method. , 2017, International journal of radiation oncology, biology, physics.
[2] Johannes A Langendijk,et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Alfred R. Smith,et al. Vision 20/20: proton therapy. , 2009, Medical physics.
[4] Timothy C Y Chan,et al. Accounting for range uncertainties in the optimization of intensity modulated proton therapy , 2007, Physics in medicine and biology.
[5] A. Lühr,et al. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy , 2015, Acta oncologica.
[6] J. Wunder,et al. Chordoma: long-term follow-up after radical photon irradiation. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Lei Xing,et al. Optimization approaches to volumetric modulated arc therapy planning. , 2015, Medical physics.
[8] Non-uniform spatiotemporal fractionation schemes in photon radiotherapy , 2015 .
[9] Radhe Mohan,et al. Proton therapy - Present and future. , 2017, Advanced drug delivery reviews.
[10] Anders Forsgren,et al. Minimax optimization for handling range and setup uncertainties in proton therapy. , 2011, Medical physics.
[11] B. Yeap,et al. Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas , 2014, Journal of surgical oncology.
[12] Radhe Mohan,et al. Robust optimization of intensity modulated proton therapy. , 2012, Medical physics.
[13] Thomas Bortfeld,et al. Evolution of technology to optimize the delivery of proton therapy: the third generation. , 2013, Seminars in radiation oncology.
[14] J. Régis,et al. Stereotactic body radiotherapy for de novo spinal metastases: systematic review. , 2017, Journal of neurosurgery. Spine.
[15] Max Dahele,et al. Using a knowledge-based planning solution to select patients for proton therapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Katia Parodi,et al. Development of the open‐source dose calculation and optimization toolkit matRad , 2017, Medical physics.
[17] Oliver Jäkel,et al. matRad - a multi-modality open source 3D treatment planning toolkit , 2015 .
[18] T. Delaney,et al. Chordomas and chondrosarcomas—The role of radiation therapy , 2016, Journal of surgical oncology.
[19] Jan Unkelbach,et al. Simultaneous optimization of dose distributions and fractionation schemes in particle radiotherapy. , 2013, Medical physics.
[20] U Oelfke,et al. Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy , 2008, Physics in medicine and biology.
[21] Dan T. L. Jones,et al. Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Philipp Hennig,et al. Analytical probabilistic modeling for radiation therapy treatment planning , 2013, Physics in medicine and biology.
[23] Thomas Bortfeld,et al. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. , 2008, Medical physics.
[24] J. Debus,et al. Treatment with heavy charged particles: Systematic review of clinical data and current clinical (comparative) trials , 2013, Acta oncologica.
[25] Jan Unkelbach,et al. Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations. , 2016, International journal of radiation oncology, biology, physics.
[26] J F Fowler,et al. 21 years of biologically effective dose. , 2010, The British journal of radiology.
[27] Dávid Papp,et al. The emergence of nonuniform spatiotemporal fractionation schemes within the standard BED model. , 2015, Medical physics.
[28] T. Delaney,et al. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. , 2006, International journal of radiation oncology, biology, physics.